Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buzzy vs. Lidocaine for IV Cannulation Pain
NCT04647084Phase 4Withdrawn
- Sponsor
- St. Elizabeth's Medical Center
- Start
- Oct 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in acute pain, sponsored by St. Elizabeth's Medical Center. Planned start Oct 2022; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04647084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647084.